logo-loader
RNS
Helios Underwriting PLC

Director/PDMR Dealing and Total Voting Rights

RNS Number : 1697D
Helios Underwriting Plc
13 November 2026
 

13 November 2026

Helios Underwriting plc

("Helios" or the "Company")

 

Director/PDMR Dealing, Correction of Previous Director/PDMR Dealing Disclosure and Total Voting Rights

 

Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd’s of London, the world’s largest insurance market, announces a correction to a previous disclosure concerning the shareholding of Andrew Christie, Non-Executive Director of the Company, a person discharging managerial responsibilities ("PDMR"), and provides details of transactions undertaken by Mr Christie in connection with the Company's Tender Offer, the results of which were announced on 30 October 2026 (the “Tender Offer”).

Correction of previous disclosure

The Company announced on 13 December 2022 that, following the transaction disclosed in that announcement, Mr Christie's resultant beneficial interest in the Company's ordinary shares of 10 pence each ("Ordinary Shares") was 34,551 Ordinary Shares.

The Company has subsequently identified that, as a result of a clerical error, the resultant holding stated in that announcement was incorrect. Mr Christie's correct resultant holding at that time was 35,551 Ordinary Shares.

Following the subsequent receipt of scrip dividends in 2024 and 2025, Mr Christie's holding increased to 35,920 Ordinary Shares immediately prior to the Tender Offer.

Tender Offer and corrective purchase

As announced on 30 October 2026, the Company undertook the Tender Offer pursuant to which eligible shareholders were able to tender Ordinary Shares at a price of 269p per Ordinary Share (the "Tender Price").

As a result of an administrative error by Mr Christie's custodian bank, 6,009 Ordinary Shares held by Mr Christie were sold pursuant to the Tender Offer at the Tender Price. Mr Christie had intended that only 1,050 Ordinary Shares be sold pursuant to the Tender Offer, being the number of Ordinary Shares representing the same proportion of his holding as the proportion successfully tendered by other shareholders under the Tender Offer.

In order to rectify the effect of this administrative error and restore Mr Christie to the position he would have been in had only 1,050 Ordinary Shares been sold pursuant to the Tender Offer, on 13 November 2026 Mr Christie purchased back 4,959 Ordinary Shares at the Tender Price from the Company.

Following this purchase, Mr Christie has a resulting beneficial interest in 34,870 Ordinary Shares.

No further directors or PDMRs tendered their shares under the Tender Offer.

Total Voting Rights

Following the correction detailed above, the Company’s issued share capital will comprise 73,363,432 Ordinary Shares of which 6,529,087 are held in treasury. Therefore, the total voting rights in Helios will be 66,834,345. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

The notifications below, which have been made in accordance with the requirement of the UK Market Abuse Regulation, provide further details.

For further information, please contact:

Helios Underwriting plc

Louis Tucker – Chief Executive Officer   +44 (0)20 3965 6441 

Adhiraj Maitra – Director of Finance and Operations +44 (0)20 3743 2114

 

Peel Hunt (Nomad, Broker and Financial Adviser) 

Dan Webster / Andrew Buchanan / Martin Frowde +44 (0)20 7418 8900

 

Singer Capital Markets (Joint Broker)

Charles Leigh-Pemberton / Russell Cook / James Todd   +44 (0)20 7496 3000

 

FTI Consulting

Ed Berry      +44 (0)7703 330 199

Christian Harte        +44 (0)7974 288 763

 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Andrew Christie

2

Reason for the notification


a)


Position/status

 

 

Director

b)

Initial notification/Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting Plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10 pence each

 

ISIN - GB00B23XLS45

b)

Nature of the transaction

 

Disposal of Ordinary Shares pursuant to the Tender Offer

c)

Price(s) and volume(s)

   

Price(s)

Volume(s)

Sale: 269p

6,009

 

 

d)

Aggregated information

 

Price(s)

Volume(s)

Sale: 269p

6,009

e)

Date of the transaction

 3 November 2026

f)

Place of the transaction  

 

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Andrew Christie

2

Reason for the notification


a)


Position/status

 

 

Director

b)

Initial notification/Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting Plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10 pence each

 

ISIN - GB00B23XLS45

b)

Nature of the transaction

 

Purchase of Ordinary Shares to rectify the administrative error described above

c)

Price(s) and volume(s)

   

Price(s)

Volume(s)

Purchase: 269p

4,959

 

 

d)

Aggregated information

 

Price(s)

Volume(s)

Purchase: 269p

4,959

e)

Date of the transaction

 12 November 2026

f)

Place of the transaction  

 

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFELALVLIR
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Director/PDMR Shareholding

1 week, 2 days ago

Director/PDMR Shareholding

1 week, 3 days ago

Holding(s) in Company

2 weeks, 3 days ago

Result of Tender Offer

2 weeks, 6 days ago

Results of General Meeting

3 weeks, 3 days ago

Total Voting Rights

on 10/01/2026

5 min read